Press Releases September 3, 2026 04:05 PM

CapsoVision to Participate in Upcoming Investor Conferences

CapsoVision Announces Participation in Upcoming Investor Conferences to Present Advances in AI-Enabled Capsule Endoscopy

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
CV

CapsoVision, Inc., a NASDAQ-listed medical technology company specializing in AI-enabled capsule endoscopy solutions, announced that its executive team will participate in the H.C. Wainwright Global Investment Conference and the ROTH Healthcare Opportunities Conference. The presentations aim to highlight its advanced imaging products for gastrointestinal disease detection and the company’s pipeline developments.

CapsoVision to Participate in Upcoming Investor Conferences
CV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CapsoVision will present at two major investor conferences in September 2026, including H.C. Wainwright and ROTH Healthcare Conferences.
  • The company focuses on AI-enabled capsule endoscopy technology for gastrointestinal disease detection, including its flagship CapsoCam Plus and upcoming CapsoCam Colon products.
  • Participation in these conferences provides an opportunity to engage directly with investors and highlight the company’s innovative pipeline and growth potential.

SARATOGA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, President and Chief Executive Officer, David Garcia, Senior Vice President of Finance, and Doug Atkinson, Senior Vice President of Global Sales, plan to participate in the following upcoming investor conferences:

H.C. Wainwright 28th Annual Global Investment Conference (September 14-16 in New York City)

  • Format: On-demand Company Presentation and 1x1 Investor Meetings
  • Date/Time:
    • On-demand Company Presentation – Friday, September 11, 2026, beginning at 7:00 am ET
    • 1x1 Investor Meetings – Monday, September 14, 2026

5th Annual ROTH Healthcare Opportunities Conference (September 29 in New York City)

  • Format: 1x1 Investor Meetings
  • Date/Time: Tuesday, September 29, 2026

The on-demand presentation will be available on the Events page in the investor relations section of the company’s website for 90 days. If you are interested in arranging a one-on-one meeting with CapsoVision’s management team at the conferences, please contact your respective H.C. Wainwright and Roth representatives or reach out to the company directly at [email protected].

About CapsoVision

CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and screening of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval. The Company’s next pipeline product, CapsoCam Colon™ with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection. With a proprietary platform targeted to expand across multiple GI indications, including esophageal and pancreatic disorders, CapsoVision is advancing a new era in capsule-based diagnostics. For more information on CapsoVision, please visit www.capsovision.com.

Investor Relations Contact
Leigh Salvo
New Street Investor Relations
[email protected]

Media Contact
Leslie Strickler and Paul Spicer
Être Communications
[email protected] | (804) 240-0807
[email protected] | (804) 503-9231


Risks

  • Market adoption and regulatory approval risks associated with new medical technologies like AI-enabled capsule endoscopy affect company growth.
  • Competitive pressures in the medical imaging and diagnostic sectors could impact CapsoVision's market share and profitability.
  • Uncertainties related to commercialization and reimbursement in healthcare systems may affect the financial outlook of the company.

More from Press Releases

Tenable Uses OpenAI GPT Cyber Models to Help Defenders Inspect Community-Built AI Components Sep 3, 2026 XTEND Reality Expansion Ltd. and JFB Construction Holdings Complete Business Combination, Raising $110 Million in Total Capital Sep 3, 2026 Freshworks Announces Inducement Grant under Listing Rule 5635(C)(4) of the Nasdaq Stock Market Sep 3, 2026 Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS Sep 3, 2026 Rogers and Quebecor Agree to New 12-Year Sublicensing Deal for National NHL Games in French Sep 3, 2026